VDUP1 mediates nuclear export of HIF1α via CRM1-dependent pathway

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1783, Issue 5, 2008, Pages 838-848

  Shin, Daesung ^a   Jeon, Jun Ho ^a   Jeong, Mira ^a   Suh, Hyun Woo ^a   Kim, Seyl ^a   Kim, Hyoung Chin ^a   Moon, Og Sung ^a   Kim, Yong Sung ^a   Chung, Jin Woong ^a   Yoon, Suk Ran ^a   Kim, Woo Ho ^b   Choi, Inpyo ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

CRM1; HIF1 ; pVHL; Transport; VDUP1

Indexed keywords

EXPORTIN 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; SMALL INTERFERING RNA; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; VITAMIN D2 UPREGULATED PROTEIN 1; VON HIPPEL LINDAU PROTEIN;

ARTICLE; CANCER CELL CULTURE; CELL INVASION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; IN VITRO STUDY; IN VIVO STUDY; KAPLAN MEIER METHOD; METASTASIS; NUCLEAR EXPORT SIGNAL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; RNA INTERFERENCE;

ACTIVE TRANSPORT, CELL NUCLEUS; CARRIER PROTEINS; CELL LINE; CELL NUCLEUS; HELA CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; KARYOPHERINS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEINS; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 41949104389     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2007.10.012     Document Type: Article

References (39)

1. Poellinger L., and Johnson R.S. HIF-1 and hypoxic response: the plot thickens. Curr. Opin. Genet. Dev. 14 (2004) 81-85
2. Schofield C.J., and Ratcliffe P.J. Oxygen sensing by HIF hydroxylases. Nat. Rev. Mol. Cell Biol. 5 (2004) 343-354
3. Nakamura H., Makino Y., Okamoto K., Poellinger L., Ohnuma K., Morimoto C., and Tanaka H. TCR engagement increases hypoxia-inducible factor-1alpha protein synthesis via rapamycin-sensitive pathway under hypoxic conditions in human peripheral T cells. J. Immunol. 174 (2005) 7592-7599
4. Peyssonnaux C., Datta V., Cramer T., Doedens A., Theodorakis E.A., Gallo R.L., Hurtado-Ziola N., Nizet V., and Johnson R.S. HIF-1alpha expression regulates the bactericidal capacity of phagocytes. J. Clin. Invest. 115 (2005) 1806-1815
5. Mazure N.M., Brahimi-Horn M.C., Berta M.A., Benizri E., Bilton R.L., Dayan F., Ginouves A., Berra E., and Pouyssegur J. HIF-1: master and commander of the hypoxic world. A pharmacological approach to its regulation by siRNAs. Biochem. Pharmacol. 68 (2004) 971-980
6. Lee J.W., Bae S.H., Jeong J.W., Kim S.H., and Kim K.W. Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions. Exp. Mol. Med. 36 (2004) 1-12
7. Tanimoto K., Makino Y., Pereira T., and Poellinger L. Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein. Embo. J. 19 (2000) 4298-4309
8. Groulx I., and Lee S. Oxygen-dependent ubiquitination and degradation of hypoxia-inducible factor requires nuclear-cytoplasmic trafficking of the von Hippel-Lindau tumor suppressor protein. Mol. Cell. Biol. 22 (2002) 5319-5336
9. Semenza G.L. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 3 (2003) 721-732
10. Goldberg S.F., Miele M.E., Hatta N., Takata M., Paquette-Straub C., Freedman L.P., and Welch D.R. Melanoma metastasis suppression by chromosome 6: evidence for a pathway regulated by CRSP3 and TXNIP. Cancer Res. 63 (2003) 432-440
11. Jeon J.H., Lee K.N., Hwang C.Y., Kwon K.S., You K.H., and Choi I. Tumor suppressor VDUP1 increases p27(kip1) stability by inhibiting JAB1. Cancer Res. 65 (2005) 4485-4489
12. Lee K.N., Kang H.S., Jeon J.H., Kim E.M., Yoon S.R., Song H., Lyu C.Y., Piao Z.H., Kim S.U., Han Y.H., Song S.S., Lee Y.H., Song K.S., Kim Y.M., Yu D.Y., and Choi I. VDUP1 is required for the development of natural killer cells. Immunity 22 (2005) 195-208
13. Zhou J., Schmid T., and Brune B. Tumor necrosis factor-alpha causes accumulation of a ubiquitinated form of hypoxia inducible factor-1alpha through a nuclear factor-kappaB-dependent pathway. Mol. Biol. Cell 14 (2003) 2216-2225
14. Jung Y., Isaacs J.S., Lee S., Trepel J., Liu Z.G., and Neckers L. Hypoxia-inducible factor induction by tumour necrosis factor in normoxic cells requires receptor-interacting protein-dependent nuclear factor kappa B activation. Biochem. J. 370 (2003) 1011-1017
15. Junn E., Han S.H., Im J.Y., Yang Y., Cho E.W., Um H.D., Kim D.K., Lee K.W., Han P.L., Rhee S.G., and Choi I. Vitamin D3 up-regulated protein 1 mediates oxidative stress via suppressing the thioredoxin function. J. Immunol. 164 (2000) 6287-6295
16. Welsh S.J., Bellamy W.T., Briehl M.M., and Powis G. The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis. Cancer Res. 62 (2002) 5089-5095
17. Jaakkola P., Mole D.R., Tian Y.M., Wilson M.I., Gielbert J., Gaskell S.J., Kriegsheim A., Hebestreit H.F., Mukherji M., Schofield C.J., Maxwell P.H., Pugh C.W., and Ratcliffe P.J. Targeting of HIF-?to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292 (2001) 468-472
18. Bonicalzi M.E., Groulx I., de Paulsen N., and Lee S. Role of exon 2-encoded beta -domain of the von Hippel-Lindau tumor suppressor protein. J. Biol. Chem. 276 (2001) 1407-1416
19. Maxwell P.H., Wiesener M.S., Chang G.W., Clifford S.C., Vaux E.C., Cockman M.E., Wykoff C.C., Pugh C.W., Maher E.R., and Ratcliffe P.J. The tumor suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399 (1999) 271-275
20. Kallio P.J., Okamoto K., O'Brien S., Carrero P., Makino Y., Tanaka H., and Poellinger L. Signal transduction in hypoxic cells: inducible nuclear translocation and recruitment of the CBP/p300 coactivator by the hypoxia-inducible factor-1alpha. EMBO J. 17 (1998) 6573-6586
21. Nishinaka Y., Masutani H., Oka S., Matsuo Y., Yamaguchi Y., Nishio K., Ishii Y., and Yodoi J. Importin alpha1 (Rch1) mediates nuclear translocation of thioredoxin-binding protein-2/vitamin D(3)-up-regulated protein 1. J. Biol. Chem. 279 (2004) 37559-37565
22. la Cour T., Kiemer L., Molgaard A., Gupta R., Skriver K., and Brunak S. Analysis and prediction of leucine-rich nuclear export signals. Protein Eng. Des. Sel. 17 (2004) 527-536
23. Kudo N., Wolff B., Sekimoto T., Schreiner E.P., Yoneda Y., Yanagida M., Horinouchi S., and Yoshida M. Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1. Exp. Cell Res. 242 (1998) 540-547
24. Krishnamachary B., Berg-Dixon S., Kelly B., Agani F., Feldser D., Ferreira G., Iyer N., LaRusch J., Pak B., Taghavi P., and Semenza G.L. Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. Cancer Res. 63 (2003) 1138-1143
25. J.J., Han S.H., Ju H.R., Jung U., Kim K.Y., Yoo H.S., Lee Y.H., Song K.S., Hwang H.M., Na Y.S., Yang Y., Lee K.N., and Choi I. VDUP1 upregulated by TGF-beta1 and 1,25-dihydorxyvitamin D3 inhibits tumor cell growth by blocking cell-cycle progression. Oncogene 22 (2003) 4035-4046
26. M.M., Goldberg S.F., Hatta N., Takata M., Paquette-Straub C., Freedman L.P., and Welch D.R. Melanoma metastasis suppression by chromosome 6: evidence for a pathway regulated by CRSP3 and TXNIP. Cancer Res. 63 (2003) 432-440
27. Han S.H., Jeon J.H., Ju H.R., Jung U., Kim K.Y., Yoo H.S., Lee Y.H., Song K.S., Hwang H.M., Na Y.S., Yang Y., Lee K.N., and Choi I. VDUP1 upregulated by TGF-beta1 and 1,25-dihydorxyvitamin D3 inhibits tumor cell growth by blocking cell-cycle progression. Oncogene 22 (2003) 4035-4046
28. Xu L., and Massague J. Nucleocytoplasmic shuttling of signal transducers. Nat. Rev. Mol. Cell Biol. 5 (2004) 209-219
29. Ishida N., Hara T., Kamura T., Yoshida M., Nakayama K., and Nakayama K.I. Phosphorylation of p27Kip1 on serine 10 is required for its binding to CRM1 and nuclear export. J. Biol. Chem. 277 (2002) 14355-14358
30. Baek S.H., and Rosenfeld M.G. Nuclear receptor coregulators: their modification codes and regulatory mechanism by translocation. Biochem. Biophys. Res. Commun. 319 (2004) 707-714
31. Rodriguez J.A., Schuchner S., Au W.W., Fabbro M., and Henderson B.R. Nuclear-cytoplasmic shuttling of BARD1 contributes to its proapoptotic activity and is regulated by dimerization with BRCA1. Oncogene 23 (2004) 1809-1820
32. Groulx I., Bonicalzi M.E., and Lee S. Ran-mediated nuclear export of the von Hippel-Lindau tumor suppressor protein occurs independently of its assembly with Cullin-2. J. Biol. Chem. 275 (2000) 8991-9000
33. Zgouras D., Wachtershauser A., Frings D., and Stein J. Butyrate impairs intestinal tumor cell-induced angiogenesis by inhibiting HIF-1alpha nuclear translocation. Biochem. Biophys. Res. Commun. 300 (2003) 832-838
34. Mekhail K., Gunaratnam L., Bonicalzi M.E., and Lee S. HIF activation by pH-dependent nucleolar sequestration of VHL. Nat. Cell Biol. 6 (2004) 642-647
35. Bardos J.I., and Ashcroft M. Negative and positive regulation of HIF-1: a complex network. Biochim. Biophys. Acta (2005)
36. Bardos J.I., and Ashcroft M. Negative and positive regulation of HIF-1: a complex network. Biochim. Biophys. Acta 1755 (2005) 107-120
37. Czyzyk-Krzeska M.J., and M.F. von Hippel-Lindau tumor suppressor: not only HIF's executioner. Trends Mol. Med. 10 (2004) 146-149
38. Zheng X., Ruas J.L., Cao R., Salomons F.A., Cao Y., Poellinger L., and Pereira T. Cell-type-specific regulation of degradation of hypoxia-inducible factor 1 alpha: role of subcellular compartmentalization. Mol. Cell Biol. 26 (2006) 4628-4641
39. Lee S., Chen D.Y., Humphrey J.S., Gnarra J.R., Linehan W.M., and Klausner R.D. Nuclear/cytoplasmic localization of the von Hippel-Lindau tumor suppressor gene product is determined by cell density. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 1770-1775